EUA
AdvanSure SARS-CoV-2 IgG(RBD) ELISA
FDA Emergency Use Authorization · LG Chem, Ltd. · May 31, 2022
Key facts
| Product | AdvanSure SARS-CoV-2 IgG(RBD) ELISA |
|---|---|
| Company | LG Chem, Ltd. |
| Product type | IgG, ELISA |
| Date | May 31, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: